Adipocyte-secreted exosomal microRNA-34a inhibits M2 macrophage polarization to promote obesity-induced adipose inflammation

Persistent, unresolved inflammation in adipose tissue is a major contributor to obesity-associated metabolic complications. However, the molecular links between lipid-overloaded adipocytes and inflammatory immune cells in obese adipose tissues remain elusive. Here we identified adipocyte-secreted mi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of clinical investigation Jg. 129; H. 2; S. 834 - 849
Hauptverfasser: Pan, Yong, Hui, Xiaoyan, Hoo, Ruby Lai Chong, Ye, Dewei, Chan, Cyrus Yuk Cheung, Feng, Tianshi, Wang, Yu, Lam, Karen Siu Ling, Xu, Aimin
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States American Society for Clinical Investigation 01.02.2019
Schlagworte:
ISSN:0021-9738, 1558-8238, 1558-8238
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Persistent, unresolved inflammation in adipose tissue is a major contributor to obesity-associated metabolic complications. However, the molecular links between lipid-overloaded adipocytes and inflammatory immune cells in obese adipose tissues remain elusive. Here we identified adipocyte-secreted microRNA-34a (miR-34a) as a key mediator through its paracrine actions on adipose-resident macrophages. The expression of miR-34a in adipose tissues was progressively increased with the development of dietary obesity. Adipose-selective or adipocyte-specific miR-34a-KO mice were resistant to obesity-induced glucose intolerance, insulin resistance, and systemic inflammation, and this was accompanied by a significant shift in polarization of adipose-resident macrophages from proinflammatory M1 to antiinflammatory M2 phenotype. Mechanistically, mature adipocyte-secreted exosomes transported miR-34a into macrophages, thereby suppressing M2 polarization by repressing the expression of Krüppel-like factor 4 (Klf4). The suppressive effects of miR-34a on M2 polarization and its stimulation of inflammatory responses were reversed by ectopic expression of Klf4 in both bone marrow-derived macrophages and adipose depots of obese mice. Furthermore, increased miR-34a expression in visceral fat of overweight/obese subjects correlated negatively with reduced Klf4 expression, but positively with the parameters of insulin resistance and metabolic inflammation. In summary, miR-34a was a key component of adipocyte-secreted exosomal vesicles that transmitted the signal of nutrient overload to the adipose-resident macrophages for exacerbation of obesity-induced systemic inflammation and metabolic dysregulation.
AbstractList Persistent, unresolved inflammation in adipose tissue is a major contributor to obesity-associated metabolic complications. However, the molecular links between lipid-overloaded adipocytes and inflammatory immune cells in obese adipose tissues remain elusive. Here we identified adipocyte-secreted microRNA-34a (miR-34a) as a key mediator through its paracrine actions on adipose-resident macrophages. The expression of miR-34a in adipose tissues was progressively increased with the development of dietary obesity. Adipose-selective or adipocyte-specific miR-34a-KO mice were resistant to obesity-induced glucose intolerance, insulin resistance, and systemic inflammation, and this was accompanied by a significant shift in polarization of adipose-resident macrophages from proinflammatory M1 to antiinflammatory M2 phenotype. Mechanistically, mature adipocyte-secreted exosomes transported miR-34a into macrophages, thereby suppressing M2 polarization by repressing the expression of Kruppel-like factor 4 (Klf4). The suppressive effects of miR-34a on M2 polarization and its stimulation of inflammatory responses were reversed by ectopic expression of Klf4 in both bone marrow-derived macrophages and adipose depots of obese mice. Furthermore, increased miR-34a expression in visceral fat of overweight/obese subjects correlated negatively with reduced Klf4 expression, but positively with the parameters of insulin resistance and metabolic inflammation. In summary, miR-34a was a key component of adipocyte-secreted exosomal vesicles that transmitted the signal of nutrient overload to the adipose-resident macrophages for exacerbation of obesity-induced systemic inflammation and metabolic dysregulation.
Persistent, unresolved inflammation in adipose tissue is a major contributor to obesity-associated metabolic complications. However, the molecular links between lipid-overloaded adipocytes and inflammatory immune cells in obese adipose tissues remain elusive. Here we identified adipocyte-secreted microRNA-34a (miR-34a) as a key mediator through its paracrine actions on adipose-resident macrophages. The expression of miR-34a in adipose tissues was progressively increased with the development of dietary obesity. Adipose-selective or adipocyte-specific miR-34a–KO mice were resistant to obesity-induced glucose intolerance, insulin resistance, and systemic inflammation, and this was accompanied by a significant shift in polarization of adipose-resident macrophages from proinflammatory M1 to antiinflammatory M2 phenotype. Mechanistically, mature adipocyte-secreted exosomes transported miR-34a into macrophages, thereby suppressing M2 polarization by repressing the expression of Krüppel-like factor 4 (Klf4). The suppressive effects of miR-34a on M2 polarization and its stimulation of inflammatory responses were reversed by ectopic expression of Klf4 in both bone marrow–derived macrophages and adipose depots of obese mice. Furthermore, increased miR-34a expression in visceral fat of overweight/obese subjects correlated negatively with reduced Klf4 expression, but positively with the parameters of insulin resistance and metabolic inflammation. In summary, miR-34a was a key component of adipocyte-secreted exosomal vesicles that transmitted the signal of nutrient overload to the adipose-resident macrophages for exacerbation of obesity-induced systemic inflammation and metabolic dysregulation.
Persistent, unresolved inflammation in adipose tissue is a major contributor to obesity-associated metabolic complications. However, the molecular links between lipid-overloaded adipocytes and inflammatory immune cells in obese adipose tissues remain elusive. Here we identified adipocyte-secreted microRNA-34a (miR-34a) as a key mediator through its paracrine actions on adipose-resident macrophages. The expression of miR-34a in adipose tissues was progressively increased with the development of dietary obesity. Adipose-selective or adipocyte-specific miR-34a-KO mice were resistant to obesity-induced glucose intolerance, insulin resistance, and systemic inflammation, and this was accompanied by a significant shift in polarization of adipose-resident macrophages from proinflammatory M1 to antiinflammatory M2 phenotype. Mechanistically, mature adipocyte-secreted exosomes transported miR-34a into macrophages, thereby suppressing M2 polarization by repressing the expression of Krüppel-like factor 4 (Klf4). The suppressive effects of miR-34a on M2 polarization and its stimulation of inflammator y responses were reversed by ectopic expression of Klf4 in both bone marrow-derived macrophages and adipose depots of obese mice. Furthermore, increased miR-34a expression in visceral fat of overweight/obese subjects correlated negatively with reduced Klf4 expression, but positively with the parameters of insulin resistance and metabolic inflammation. In summar y, miR-34a was a key component of adipocyte-secreted exosomal vesicles that transmitted the signal of nutrient overload to the adipose-resident macrophages for exacerbation of obesity-induced systemic inflammation and metabolic dysregulation.
Persistent, unresolved inflammation in adipose tissue is a major contributor to obesity-associated metabolic complications. However, the molecular links between lipid-overloaded adipocytes and inflammatory immune cells in obese adipose tissues remain elusive. Here we identified adipocyte-secreted microRNA-34a (miR-34a) as a key mediator through its paracrine actions on adipose-resident macrophages. The expression of miR-34a in adipose tissues was progressively increased with the development of dietary obesity. Adipose-selective or adipocyte-specific miR-34a-KO mice were resistant to obesity-induced glucose intolerance, insulin resistance, and systemic inflammation, and this was accompanied by a significant shift in polarization of adipose-resident macrophages from proinflammatory M1 to antiinflammatory M2 phenotype. Mechanistically, mature adipocyte-secreted exosomes transported miR-34a into macrophages, thereby suppressing M2 polarization by repressing the expression of Krüppel-like factor 4 (Klf4). The suppressive effects of miR-34a on M2 polarization and its stimulation of inflammatory responses were reversed by ectopic expression of Klf4 in both bone marrow-derived macrophages and adipose depots of obese mice. Furthermore, increased miR-34a expression in visceral fat of overweight/obese subjects correlated negatively with reduced Klf4 expression, but positively with the parameters of insulin resistance and metabolic inflammation. In summary, miR-34a was a key component of adipocyte-secreted exosomal vesicles that transmitted the signal of nutrient overload to the adipose-resident macrophages for exacerbation of obesity-induced systemic inflammation and metabolic dysregulation.Persistent, unresolved inflammation in adipose tissue is a major contributor to obesity-associated metabolic complications. However, the molecular links between lipid-overloaded adipocytes and inflammatory immune cells in obese adipose tissues remain elusive. Here we identified adipocyte-secreted microRNA-34a (miR-34a) as a key mediator through its paracrine actions on adipose-resident macrophages. The expression of miR-34a in adipose tissues was progressively increased with the development of dietary obesity. Adipose-selective or adipocyte-specific miR-34a-KO mice were resistant to obesity-induced glucose intolerance, insulin resistance, and systemic inflammation, and this was accompanied by a significant shift in polarization of adipose-resident macrophages from proinflammatory M1 to antiinflammatory M2 phenotype. Mechanistically, mature adipocyte-secreted exosomes transported miR-34a into macrophages, thereby suppressing M2 polarization by repressing the expression of Krüppel-like factor 4 (Klf4). The suppressive effects of miR-34a on M2 polarization and its stimulation of inflammatory responses were reversed by ectopic expression of Klf4 in both bone marrow-derived macrophages and adipose depots of obese mice. Furthermore, increased miR-34a expression in visceral fat of overweight/obese subjects correlated negatively with reduced Klf4 expression, but positively with the parameters of insulin resistance and metabolic inflammation. In summary, miR-34a was a key component of adipocyte-secreted exosomal vesicles that transmitted the signal of nutrient overload to the adipose-resident macrophages for exacerbation of obesity-induced systemic inflammation and metabolic dysregulation.
Audience Academic
Author Feng, Tianshi
Lam, Karen Siu Ling
Chan, Cyrus Yuk Cheung
Pan, Yong
Wang, Yu
Ye, Dewei
Hui, Xiaoyan
Hoo, Ruby Lai Chong
Xu, Aimin
AuthorAffiliation 3 Department of Pharmacy and Pharmacology, The University of Hong Kong, Hong Kong, China
5 Guangdong Research Center of Metabolic Diseases of Integrated Western and Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China
4 Joint Laboratory between Guangdong and Hong Kong on Metabolic Diseases, Guangdong Pharmaceutical University, Guangzhou, China
1 State Key Laboratory of Pharmaceutical Biotechnology
2 Department of Medicine, and
AuthorAffiliation_xml – name: 2 Department of Medicine, and
– name: 1 State Key Laboratory of Pharmaceutical Biotechnology
– name: 3 Department of Pharmacy and Pharmacology, The University of Hong Kong, Hong Kong, China
– name: 4 Joint Laboratory between Guangdong and Hong Kong on Metabolic Diseases, Guangdong Pharmaceutical University, Guangzhou, China
– name: 5 Guangdong Research Center of Metabolic Diseases of Integrated Western and Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China
Author_xml – sequence: 1
  givenname: Yong
  orcidid: 0000-0001-6202-433X
  surname: Pan
  fullname: Pan, Yong
– sequence: 2
  givenname: Xiaoyan
  orcidid: 0000-0002-7525-5812
  surname: Hui
  fullname: Hui, Xiaoyan
– sequence: 3
  givenname: Ruby Lai Chong
  surname: Hoo
  fullname: Hoo, Ruby Lai Chong
– sequence: 4
  givenname: Dewei
  orcidid: 0000-0003-1295-3063
  surname: Ye
  fullname: Ye, Dewei
– sequence: 5
  givenname: Cyrus Yuk Cheung
  surname: Chan
  fullname: Chan, Cyrus Yuk Cheung
– sequence: 6
  givenname: Tianshi
  surname: Feng
  fullname: Feng, Tianshi
– sequence: 7
  givenname: Yu
  orcidid: 0000-0001-8697-2940
  surname: Wang
  fullname: Wang, Yu
– sequence: 8
  givenname: Karen Siu Ling
  surname: Lam
  fullname: Lam, Karen Siu Ling
– sequence: 9
  givenname: Aimin
  surname: Xu
  fullname: Xu, Aimin
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30667374$$D View this record in MEDLINE/PubMed
BookMark eNqNkk1vEzEQhi1URNPCgT-AVkJCcNjW9tpe7wUpivgIKlQqH1fL650krrzrZe1FDeLH45QSkioH5IMlzzPvjGfeE3TU-Q4QekrwGSElPf8wmxNaYFE9QBPCucwlLeQRmmBMSV6VhTxGJyFcY0wY4-wROk6sKIuSTdCvaWN7b9YR8gBmgAhNBjc--Fa7rLVm8FefpnnBdGa7la1tDNlHmrU6BfqVXkLWe6cH-1NH67ss-qwffOsjZL6GYOM6t10zmiSqN3UCJJmF0217yz9GDxfaBXhyd5-ir2_ffJm9zy8u381n04vcpC5jXje84FyYGlglOZNUUy2hNnRBuahwZSSthNSCaU0wM4KDFA1uCg0FL6VsilP0-o9uP9YtNAa6OGin-sG2elgrr63aj3R2pZb-hxKpLiUsCby8Exj89xFCVK0NBpzTHfgxKErKiuGKcZLQ5_fQaz8OXfpeomTBRUHJDrXUDlSaiU91zUZUTXnJSCkYFYnKD1BL6CA1mSywsOl5jz87wKfTQFrlwYRXewmJiXATl3oMQc0_X_0_e_ltn32xw65Au7gK3o2bpYd98NnuZrYr-WvQf1WT4UIYYLFFCFYb86ut-RN7fo81Nt4aLY3BugMZvwFgEgKP
CitedBy_id crossref_primary_10_1186_s12944_020_01342_3
crossref_primary_10_3389_fimmu_2025_1597210
crossref_primary_10_1007_s11695_025_07798_5
crossref_primary_10_1016_j_jep_2023_117530
crossref_primary_10_1093_advances_nmaa105
crossref_primary_10_1016_j_diabres_2024_111837
crossref_primary_10_1186_s12864_023_09141_7
crossref_primary_10_1096_fba_2020_00147
crossref_primary_10_3390_ijms221910343
crossref_primary_10_1002_mnfr_202300374
crossref_primary_10_1002_j_2040_4603_2023_tb00279_x
crossref_primary_10_1016_j_omtn_2021_08_028
crossref_primary_10_1134_S199075082202010X
crossref_primary_10_3389_fendo_2021_789939
crossref_primary_10_1289_EHP12785
crossref_primary_10_1097_IN9_0000000000000033
crossref_primary_10_1016_j_ncrna_2024_11_004
crossref_primary_10_3390_v16111785
crossref_primary_10_1186_s13000_019_0914_1
crossref_primary_10_1002_jcla_24138
crossref_primary_10_3390_cells8121581
crossref_primary_10_3389_fimmu_2022_1050188
crossref_primary_10_1007_s11154_020_09625_x
crossref_primary_10_3390_ijms22031144
crossref_primary_10_1111_aji_13841
crossref_primary_10_3389_fcell_2023_1101844
crossref_primary_10_1016_j_mad_2025_112078
crossref_primary_10_1002_jev2_12468
crossref_primary_10_1002_biof_70003
crossref_primary_10_1186_s12933_024_02404_x
crossref_primary_10_1111_cas_15679
crossref_primary_10_1016_S2468_1253_20_30252_1
crossref_primary_10_1161_ATVBAHA_119_312005
crossref_primary_10_3390_nu11102493
crossref_primary_10_1016_j_ejcb_2022_151221
crossref_primary_10_1186_s12979_022_00320_w
crossref_primary_10_3389_fendo_2024_1365156
crossref_primary_10_1002_oby_24146
crossref_primary_10_1111_sms_70097
crossref_primary_10_1111_imr_13027
crossref_primary_10_1111_liv_15490
crossref_primary_10_1111_obr_13755
crossref_primary_10_1038_s41423_025_01323_5
crossref_primary_10_1097_IN9_0000000000000027
crossref_primary_10_1016_j_phrs_2024_107345
crossref_primary_10_1016_j_bbrep_2024_101888
crossref_primary_10_3389_fimmu_2023_1213415
crossref_primary_10_1080_21655979_2021_1952817
crossref_primary_10_3389_fimmu_2022_705472
crossref_primary_10_1038_s41392_021_00779_x
crossref_primary_10_1186_s12929_025_01124_y
crossref_primary_10_1186_s12931_022_02263_8
crossref_primary_10_3389_fimmu_2025_1598407
crossref_primary_10_3389_fmed_2021_770504
crossref_primary_10_3389_fcvm_2023_1046495
crossref_primary_10_1007_s11427_024_2693_5
crossref_primary_10_1161_CIRCULATIONAHA_120_047919
crossref_primary_10_1161_CIRCULATIONAHA_120_048689
crossref_primary_10_1016_j_metabol_2021_154892
crossref_primary_10_1038_s12276_023_01072_3
crossref_primary_10_3389_fonc_2023_1288077
crossref_primary_10_3390_biom13030558
crossref_primary_10_1016_j_cyto_2024_156724
crossref_primary_10_1038_s41401_021_00736_y
crossref_primary_10_1016_j_ejphar_2020_173809
crossref_primary_10_1159_000515117
crossref_primary_10_3389_fcell_2022_910884
crossref_primary_10_3390_neuroglia3040008
crossref_primary_10_1016_j_intimp_2025_114414
crossref_primary_10_1038_s41574_023_00932_2
crossref_primary_10_1016_j_arr_2020_101175
crossref_primary_10_1096_fba_2021_00155
crossref_primary_10_3390_ncrna10020024
crossref_primary_10_1038_s41598_019_50191_3
crossref_primary_10_2337_db20_0856
crossref_primary_10_1186_s12964_023_01052_0
crossref_primary_10_1016_j_celrep_2023_112866
crossref_primary_10_3390_ijms21249366
crossref_primary_10_1111_jcmm_14628
crossref_primary_10_3390_ijms25147943
crossref_primary_10_1111_dme_14865
crossref_primary_10_1146_annurev_physiol_042222_024353
crossref_primary_10_3389_fnut_2024_1387521
crossref_primary_10_1016_j_molmet_2022_101572
crossref_primary_10_1016_j_cytogfr_2023_06_001
crossref_primary_10_3390_ijms25158042
crossref_primary_10_1111_febs_16052
crossref_primary_10_1172_JCI130892
crossref_primary_10_4049_jimmunol_2300074
crossref_primary_10_1002_jbt_23343
crossref_primary_10_1002_jcp_30699
crossref_primary_10_3389_fnut_2021_625331
crossref_primary_10_1186_s13098_020_00621_4
crossref_primary_10_1016_j_heliyon_2024_e31546
crossref_primary_10_3389_fcell_2021_647131
crossref_primary_10_1016_j_jff_2020_104147
crossref_primary_10_1038_s41574_020_0386_0
crossref_primary_10_3390_cells12040521
crossref_primary_10_1002_jcb_30478
crossref_primary_10_1038_s41467_023_36148_1
crossref_primary_10_2337_db24_0177
crossref_primary_10_3390_biom11111625
crossref_primary_10_1038_s41366_025_01907_1
crossref_primary_10_1002_prp2_1171
crossref_primary_10_2147_IJN_S419081
crossref_primary_10_1002_ctd2_134
crossref_primary_10_3389_fcvm_2021_697510
crossref_primary_10_1016_j_intimp_2022_109572
crossref_primary_10_3389_fimmu_2022_889439
crossref_primary_10_3390_jpm12020176
crossref_primary_10_1007_s11154_023_09827_z
crossref_primary_10_1186_s40168_025_02047_4
crossref_primary_10_1186_s43556_023_00158_8
crossref_primary_10_3389_fimmu_2022_901166
crossref_primary_10_4239_wjd_v14_i5_494
crossref_primary_10_3390_cells10123300
crossref_primary_10_3390_livers4030033
crossref_primary_10_1080_13813455_2022_2046106
crossref_primary_10_1038_s41366_021_00804_7
crossref_primary_10_1038_s41467_022_35470_4
crossref_primary_10_2478_fzm_2023_0008
crossref_primary_10_3390_cells9091988
crossref_primary_10_3390_ijms26136006
crossref_primary_10_3389_fimmu_2022_949670
crossref_primary_10_1186_s12951_023_01986_0
crossref_primary_10_1016_j_lfs_2023_121382
crossref_primary_10_1016_j_plipres_2023_101238
crossref_primary_10_1210_endrev_bnac009
crossref_primary_10_1016_j_phymed_2023_154952
crossref_primary_10_1007_s11095_020_02941_6
crossref_primary_10_1038_s42255_021_00446_z
crossref_primary_10_3390_cells13161309
crossref_primary_10_3390_ijms232012305
crossref_primary_10_1210_endocr_bqab250
crossref_primary_10_1186_s12967_025_06959_5
crossref_primary_10_1007_s12672_023_00704_4
crossref_primary_10_1016_j_gene_2024_148829
crossref_primary_10_3390_ijms22041788
crossref_primary_10_1007_s13679_019_00344_2
crossref_primary_10_3389_fcvm_2023_1062491
crossref_primary_10_1016_j_intimp_2025_115300
crossref_primary_10_3390_jcm11185446
crossref_primary_10_1111_aji_70123
crossref_primary_10_3390_cells11091424
crossref_primary_10_1007_s11033_022_07671_z
crossref_primary_10_3390_ijms21239313
crossref_primary_10_3892_or_2023_8627
crossref_primary_10_1038_s41385_021_00441_3
crossref_primary_10_4081_ejh_2025_4176
crossref_primary_10_1097_HC9_0000000000000089
crossref_primary_10_1002_jmv_27929
crossref_primary_10_3390_ani15172621
crossref_primary_10_1172_JCI129193
crossref_primary_10_1515_hsz_2020_0267
crossref_primary_10_1080_08820139_2022_2115379
crossref_primary_10_1002_vms3_653
crossref_primary_10_1007_s00018_021_03973_w
crossref_primary_10_1186_s40104_025_01185_x
crossref_primary_10_1096_fj_202301873RR
crossref_primary_10_3389_fimmu_2021_608680
crossref_primary_10_1111_jcmm_15872
crossref_primary_10_1002_mnfr_202100889
crossref_primary_10_1093_cvr_cvab007
crossref_primary_10_1186_s12967_022_03338_2
crossref_primary_10_3389_fgene_2020_00463
crossref_primary_10_1016_j_bbi_2024_02_016
crossref_primary_10_1007_s40519_022_01476_6
crossref_primary_10_3389_fimmu_2024_1410273
crossref_primary_10_1016_j_freeradbiomed_2021_04_031
crossref_primary_10_1007_s10456_022_09848_3
crossref_primary_10_1016_j_tem_2023_12_004
crossref_primary_10_1016_j_bbrc_2022_09_044
crossref_primary_10_1186_s12916_020_01749_w
crossref_primary_10_1016_j_yexcr_2024_114168
crossref_primary_10_1007_s00011_020_01425_y
crossref_primary_10_1016_j_ymthe_2019_09_008
crossref_primary_10_1093_asj_sjaa356
crossref_primary_10_3390_cells14171302
crossref_primary_10_3390_metabo13121190
crossref_primary_10_1089_dna_2024_0170
crossref_primary_10_3389_fphys_2021_669429
crossref_primary_10_3389_fendo_2022_839849
crossref_primary_10_1016_j_ebiom_2019_09_041
crossref_primary_10_1186_s13098_025_01837_y
crossref_primary_10_1002_1873_3468_70039
crossref_primary_10_1186_s12964_023_01431_7
crossref_primary_10_3389_fendo_2025_1638770
crossref_primary_10_1007_s11596_024_2902_2
crossref_primary_10_3390_cells11233711
crossref_primary_10_1155_2022_1252557
crossref_primary_10_2337_dc24_2739
crossref_primary_10_3389_fimmu_2022_883410
crossref_primary_10_3390_nu12051299
crossref_primary_10_1002_bies_202400203
crossref_primary_10_1111_jpn_13662
crossref_primary_10_1007_s11154_023_09850_0
crossref_primary_10_1097_MOL_0000000000000603
crossref_primary_10_3390_genes11090966
crossref_primary_10_3389_fmolb_2020_00171
crossref_primary_10_1016_j_pt_2019_07_014
crossref_primary_10_1002_bmm2_12127
crossref_primary_10_3390_biomedicines12050992
crossref_primary_10_1111_dom_15585
crossref_primary_10_1021_prechem_5c00007
crossref_primary_10_3390_cells10051004
crossref_primary_10_3390_genes16060699
crossref_primary_10_1016_j_celrep_2025_115399
crossref_primary_10_1016_j_jnutbio_2024_109639
crossref_primary_10_1016_j_jbc_2024_107328
crossref_primary_10_1186_s12933_025_02739_z
crossref_primary_10_3390_vaccines13030285
crossref_primary_10_1038_s41420_021_00670_2
crossref_primary_10_1155_2024_3759339
crossref_primary_10_2174_0109298673276581231210170332
crossref_primary_10_3390_biomedicines10071601
crossref_primary_10_1016_j_brainresbull_2024_110884
crossref_primary_10_1186_s40101_022_00286_0
crossref_primary_10_3389_fendo_2022_873865
crossref_primary_10_3390_cells11010043
crossref_primary_10_1038_s41387_022_00202_6
crossref_primary_10_3389_fendo_2022_975334
crossref_primary_10_1186_s12964_020_00581_2
crossref_primary_10_1042_BST20211031
crossref_primary_10_4103_aja202243
crossref_primary_10_1007_s00424_019_02316_w
crossref_primary_10_1038_s41419_019_1739_2
crossref_primary_10_3390_ijms22147427
crossref_primary_10_1111_obr_13691
crossref_primary_10_3390_ijms24032062
crossref_primary_10_3390_biomedicines12122752
crossref_primary_10_1016_j_imlet_2021_02_003
crossref_primary_10_3390_ijms26020788
crossref_primary_10_3390_cells11111831
crossref_primary_10_3390_cells11162581
crossref_primary_10_1016_j_phymed_2024_155850
crossref_primary_10_1016_j_ymthe_2024_06_025
crossref_primary_10_3390_biom12070982
crossref_primary_10_3389_fendo_2021_750261
crossref_primary_10_1038_s41420_022_00999_2
crossref_primary_10_1002_j_2040_4603_2023_tb00254_x
crossref_primary_10_1016_j_semcdb_2022_09_004
crossref_primary_10_1177_23982128211003484
crossref_primary_10_3390_medicina59030561
crossref_primary_10_1016_j_rvsc_2025_105772
crossref_primary_10_1038_s42255_023_00971_z
crossref_primary_10_1016_j_celrep_2025_115732
crossref_primary_10_1016_j_jbc_2022_102098
crossref_primary_10_1038_s41392_023_01333_7
crossref_primary_10_3390_ijms24032071
crossref_primary_10_3390_ijms22126337
crossref_primary_10_1186_s12967_024_06024_7
crossref_primary_10_1002_jcp_31025
crossref_primary_10_1007_s13105_024_01026_x
crossref_primary_10_1016_j_apsb_2020_12_014
crossref_primary_10_1038_s41419_020_02778_2
crossref_primary_10_1002_mnfr_202300168
crossref_primary_10_1016_j_heliyon_2023_e21615
crossref_primary_10_1186_s12964_021_00787_y
crossref_primary_10_3390_biom10050707
crossref_primary_10_3390_biom15020231
crossref_primary_10_1016_j_jgg_2024_11_011
crossref_primary_10_1002_mef2_70031
crossref_primary_10_1371_journal_pbio_3002142
crossref_primary_10_31083_j_fbl2807149
crossref_primary_10_1002_hsr2_1861
crossref_primary_10_1155_2023_9517826
crossref_primary_10_3390_biology8010008
crossref_primary_10_1016_j_abb_2024_110063
crossref_primary_10_1007_s11010_023_04809_w
crossref_primary_10_1016_j_bcp_2023_115948
crossref_primary_10_1155_2021_9709290
crossref_primary_10_3389_fimmu_2021_666344
crossref_primary_10_1016_j_cmet_2021_08_002
crossref_primary_10_1016_j_diabres_2025_112222
crossref_primary_10_1016_j_yjmcc_2019_05_012
crossref_primary_10_1038_s41598_021_95028_0
crossref_primary_10_1096_fj_202401464R
crossref_primary_10_3389_fendo_2024_1510712
crossref_primary_10_1016_j_cmet_2021_08_006
crossref_primary_10_1038_s41401_024_01238_3
crossref_primary_10_1093_lifemeta_loae003
crossref_primary_10_1007_s12094_020_02485_6
crossref_primary_10_1146_annurev_physiol_042222_024535
crossref_primary_10_1186_s11658_024_00558_w
crossref_primary_10_1186_s12933_023_01842_3
crossref_primary_10_3389_fphar_2022_1089214
crossref_primary_10_1210_endocr_bqac062
crossref_primary_10_3389_fcell_2020_587693
crossref_primary_10_1016_j_intimp_2023_109905
crossref_primary_10_1038_s41574_019_0260_0
crossref_primary_10_1016_j_jid_2020_07_009
crossref_primary_10_3389_fimmu_2021_702835
crossref_primary_10_1002_jcp_31008
crossref_primary_10_1186_s13098_023_01137_3
crossref_primary_10_1186_s12889_025_21904_3
crossref_primary_10_1007_s12010_025_05290_5
crossref_primary_10_1016_j_molmet_2022_101642
crossref_primary_10_1002_2211_5463_13471
crossref_primary_10_3390_nu13072326
crossref_primary_10_1038_s41598_020_69038_3
crossref_primary_10_3389_fimmu_2022_1014013
crossref_primary_10_3389_fnmol_2021_756499
crossref_primary_10_1093_pcmedi_pbae021
Cites_doi 10.1371/journal.pone.0004699
10.1038/sj.emboj.7601824
10.1242/jcs.155523
10.1016/j.cmet.2008.08.015
10.1016/j.cell.2009.01.002
10.2337/db09-0216
10.2337/db07-1476
10.1016/j.cmet.2015.06.004
10.1016/j.cell.2013.12.012
10.1038/nature05894
10.1038/nrc3166
10.1172/JCI19246
10.1172/JCI28898
10.1186/gb-2010-11-8-r90
10.1038/nm.1964
10.1128/MCB.01300-08
10.2337/db06-1076
10.1186/s12986-015-0016-3
10.1194/jlr.M071357
10.1038/nm.2627
10.1038/ncb1596
10.1002/oby.21709
10.1126/science.1201475
10.1038/nrendo.2015.25
10.1371/journal.pone.0009022
10.2337/db10-0650
10.1371/journal.pone.0004722
10.1038/nature21365
10.15252/embr.201643184
10.1007/s00380-018-1169-6
10.4049/jimmunol.157.8.3220
10.1111/acel.12135
10.1016/j.cmet.2008.04.002
10.1097/SHK.0b013e318162bef7
10.4049/jimmunol.1402797
10.1161/JAHA.117.007442
10.1016/j.tem.2012.05.011
10.1073/pnas.0500419102
10.1016/S0092-8674(04)00045-5
10.1073/pnas.0706832104
10.1038/nature11919
10.1073/pnas.1205951109
10.1084/jem.20121964
10.1038/nrm3313
10.1016/j.cell.2017.08.035
10.1172/JCI59643
10.1038/380630a0
10.1074/jbc.M112.350066
10.1371/journal.pone.0163424
10.2337/db11-0194
10.1038/nri3088
10.1172/JCI29881
10.1007/s00125-016-3900-0
10.1242/jcs.113.19.3365
10.1016/S0021-9258(17)32128-2
10.1152/ajpendo.00329.2010
10.2337/db11-0860
10.1007/s13238-015-0168-y
10.1002/oby.21561
10.2337/db06-0263
10.1172/JCI45444
10.1038/ncomms4485
10.1038/nature14115
10.1194/jlr.M500294-JLR200
10.1128/MCB.00596-14
10.1073/pnas.1521230113
10.1515/CCLM.2002.131
ContentType Journal Article
Copyright COPYRIGHT 2019 American Society for Clinical Investigation
Copyright American Society for Clinical Investigation Feb 2019
Copyright © 2019, American Society for Clinical Investigation 2019 American Society for Clinical Investigation
Copyright_xml – notice: COPYRIGHT 2019 American Society for Clinical Investigation
– notice: Copyright American Society for Clinical Investigation Feb 2019
– notice: Copyright © 2019, American Society for Clinical Investigation 2019 American Society for Clinical Investigation
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7RV
7X7
7XB
88A
88E
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
KB0
LK8
M0S
M1P
M7P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
S0X
7X8
5PM
DOI 10.1172/JCI123069
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Nursing & Allied Health Database
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
eLibrary
AUTh Library subscriptions: ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Biological Science Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
SIRS Editorial
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
SIRS Editorial
elibrary
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList


ProQuest Central Student
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7RV
  name: Nursing & Allied Health Database
  url: https://search.proquest.com/nahs
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1558-8238
EndPage 849
ExternalDocumentID PMC6355214
A574176426
30667374
10_1172_JCI123069
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: RGC/Collaborative Research Fund
  grantid: C7055-14G
– fundername: RGC/Collaborative Research Fund
  grantid: C7037-17W
– fundername: ;
  grantid: 02132836
– fundername: HKU matching fund for the state key laboratory of Pharmaceutical Biotechnology
  grantid: na
GroupedDBID ---
-~X
.55
.XZ
08G
08P
29K
354
36B
5GY
5RE
5RS
7RV
7X7
88E
8AO
8F7
8FE
8FH
8FI
8FJ
8R4
8R5
AAWTL
AAYXX
ABOCM
ABPMR
ABUWG
ACGFO
ACIHN
ACNCT
ACPRK
ADBBV
ADPDF
AEAQA
AENEX
AFCHL
AFFHD
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ASPBG
AVWKF
AZFZN
BAWUL
BBNVY
BCU
BEC
BENPR
BHPHI
BKEYQ
BLC
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D-I
DIK
DU5
E3Z
EBD
EBS
EJD
EMB
EMOBN
EX3
F5P
FRP
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
IOF
IOV
IPO
ISR
ITC
KQ8
L7B
LK8
M1P
M5~
M7P
NAPCQ
OBH
OCB
ODZKP
OFXIZ
OGEVE
OHH
OK1
OVD
OVIDX
OVT
P2P
P6G
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q2X
RPM
S0X
SJFOW
SV3
TEORI
TR2
TVE
UKHRP
VVN
W2D
WH7
WOQ
WOW
X7M
XSB
YFH
YHG
YKV
YOC
ZY1
~H1
3V.
88A
ALIPV
CGR
CUY
CVF
ECM
EIF
INR
M0L
NPM
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c673t-bd53556cbe4985482a2a8ebc2f256909c82968a64aa104c65e86d0d3ae35788d3
IEDL.DBID M7P
ISICitedReferencesCount 373
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000457479300038&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0021-9738
1558-8238
IngestDate Tue Nov 04 01:57:09 EST 2025
Thu Sep 04 17:47:44 EDT 2025
Mon Oct 06 18:28:18 EDT 2025
Sat Nov 29 13:50:38 EST 2025
Mon Nov 24 15:53:00 EST 2025
Sat Nov 29 10:32:28 EST 2025
Wed Nov 26 10:48:39 EST 2025
Wed Nov 26 10:48:23 EST 2025
Thu May 22 21:23:28 EDT 2025
Thu Jan 02 22:59:22 EST 2025
Sat Nov 29 01:34:31 EST 2025
Tue Nov 18 22:30:34 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Obesity
Inflammation
Adipose tissue
Macrophages
Metabolism
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c673t-bd53556cbe4985482a2a8ebc2f256909c82968a64aa104c65e86d0d3ae35788d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-8697-2940
0000-0001-6202-433X
0000-0003-1295-3063
0000-0002-7525-5812
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/6355214
PMID 30667374
PQID 2183563211
PQPubID 42166
PageCount 16
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6355214
proquest_miscellaneous_2179409451
proquest_journals_2183563211
gale_infotracmisc_A574176426
gale_infotracgeneralonefile_A574176426
gale_infotracacademiconefile_A574176426
gale_incontextgauss_ISR_A574176426
gale_incontextgauss_IOV_A574176426
gale_healthsolutions_A574176426
pubmed_primary_30667374
crossref_primary_10_1172_JCI123069
crossref_citationtrail_10_1172_JCI123069
PublicationCentury 2000
PublicationDate 2019-02-01
PublicationDateYYYYMMDD 2019-02-01
PublicationDate_xml – month: 02
  year: 2019
  text: 2019-02-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Ann Arbor
PublicationTitle The Journal of clinical investigation
PublicationTitleAlternate J Clin Invest
PublicationYear 2019
Publisher American Society for Clinical Investigation
Publisher_xml – name: American Society for Clinical Investigation
References B20
B64
B21
B65
B22
Wu (B41) 1994; 269
B66
B23
B67
Liu (B58) 2008; 30
B25
B27
B28
B29
Xie (B51) 2018; 7
B30
B31
B32
B33
B34
B35
B36
B37
B38
Akca (B40) 2002; 40
Sun (B24) 2014; 5
B39
B1
Zhang (B54) 2015; 12
B3
B4
B5
B6
B7
B8
B9
Denzer (B47) 2000; 113
Rosen (B2) 2014; 156
B42
B43
B44
B45
B46
B48
B49
Zhou (B52) 2014; 127
B50
B53
B10
B11
B55
B12
B56
B13
B57
B14
B15
B59
B16
B17
B18
Takeda (B26) 1996; 157
B19
B60
B61
B62
B63
References_xml – ident: B21
  doi: 10.1371/journal.pone.0004699
– ident: B57
  doi: 10.1038/sj.emboj.7601824
– volume: 127
  start-page: 4494
  issue: pt 20
  year: 2014
  ident: B52
  article-title: Secreted fibroblast-derived miR-34a induces tubular cell apoptosis in fibrotic kidney
  publication-title: J Cell Sci
  doi: 10.1242/jcs.155523
– ident: B31
  doi: 10.1016/j.cmet.2008.08.015
– ident: B16
  doi: 10.1016/j.cell.2009.01.002
– ident: B50
  doi: 10.2337/db09-0216
– ident: B67
  doi: 10.2337/db07-1476
– ident: B30
  doi: 10.1016/j.cmet.2015.06.004
– volume: 156
  start-page: 20
  issue: 1–2
  year: 2014
  ident: B2
  article-title: What we talk about when we talk about fat
  publication-title: Cell
  doi: 10.1016/j.cell.2013.12.012
– ident: B10
  doi: 10.1038/nature05894
– ident: B17
  doi: 10.1038/nrc3166
– ident: B5
  doi: 10.1172/JCI19246
– ident: B7
  doi: 10.1172/JCI28898
– ident: B33
  doi: 10.1186/gb-2010-11-8-r90
– ident: B44
  doi: 10.1038/nm.1964
– ident: B62
  doi: 10.1128/MCB.01300-08
– ident: B28
  doi: 10.2337/db06-1076
– volume: 12
  year: 2015
  ident: B54
  article-title: Inflamed macrophage microvesicles induce insulin resistance in human adipocytes
  publication-title: Nutr Metab (Lond)
  doi: 10.1186/s12986-015-0016-3
– ident: B42
  doi: 10.1194/jlr.M071357
– ident: B60
  doi: 10.1038/nm.2627
– ident: B48
  doi: 10.1038/ncb1596
– ident: B49
  doi: 10.1002/oby.21709
– ident: B12
  doi: 10.1126/science.1201475
– ident: B19
  doi: 10.1038/nrendo.2015.25
– ident: B22
  doi: 10.1371/journal.pone.0009022
– ident: B3
  doi: 10.2337/db10-0650
– ident: B34
  doi: 10.1371/journal.pone.0004722
– ident: B20
  doi: 10.1038/nature21365
– ident: B46
  doi: 10.15252/embr.201643184
– ident: B64
  doi: 10.1007/s00380-018-1169-6
– volume: 157
  start-page: 3220
  issue: 8
  year: 1996
  ident: B26
  article-title: Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice
  publication-title: J Immunol
  doi: 10.4049/jimmunol.157.8.3220
– ident: B66
  doi: 10.1111/acel.12135
– ident: B11
  doi: 10.1016/j.cmet.2008.04.002
– volume: 30
  start-page: 260
  issue: 3
  year: 2008
  ident: B58
  article-title: KLF4 promotes the expression, translocation, and releas eof HMGB1 in RAW264.7 macrophages in response to LPS
  publication-title: Shock
  doi: 10.1097/SHK.0b013e318162bef7
– ident: B59
  doi: 10.4049/jimmunol.1402797
– volume: 7
  issue: 5
  year: 2018
  ident: B51
  article-title: Adipose-derived exosomes exert proatherogenic effects by regulating macrophage foam cell formation and polarization
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.117.007442
– ident: B43
  doi: 10.1016/j.tem.2012.05.011
– ident: B4
  doi: 10.1073/pnas.0500419102
– ident: B15
  doi: 10.1016/S0092-8674(04)00045-5
– ident: B13
  doi: 10.1073/pnas.0706832104
– ident: B63
  doi: 10.1038/nature11919
– ident: B65
  doi: 10.1073/pnas.1205951109
– ident: B45
  doi: 10.1084/jem.20121964
– ident: B18
  doi: 10.1038/nrm3313
– ident: B35
  doi: 10.1016/j.cell.2017.08.035
– ident: B9
  doi: 10.1172/JCI59643
– ident: B27
  doi: 10.1038/380630a0
– ident: B14
  doi: 10.1074/jbc.M112.350066
– ident: B37
  doi: 10.1371/journal.pone.0163424
– ident: B32
  doi: 10.2337/db11-0194
– ident: B55
  doi: 10.1038/nri3088
– ident: B8
  doi: 10.1172/JCI29881
– ident: B39
  doi: 10.1007/s00125-016-3900-0
– volume: 113
  start-page: 3365
  issue: pt 19
  year: 2000
  ident: B47
  article-title: Exosome: from internal vesicle of the multivesicular body to intercellular signaling device
  publication-title: J Cell Sci
  doi: 10.1242/jcs.113.19.3365
– volume: 269
  start-page: 20067
  issue: 31
  year: 1994
  ident: B41
  article-title: NF-κB activation of p53. A potential mechanism for suppressing cell growth in response to stress
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(17)32128-2
– ident: B61
  doi: 10.1152/ajpendo.00329.2010
– ident: B29
  doi: 10.2337/db11-0860
– ident: B53
  doi: 10.1007/s13238-015-0168-y
– ident: B38
  doi: 10.1002/oby.21561
– ident: B1
  doi: 10.2337/db06-0263
– ident: B56
  doi: 10.1172/JCI45444
– volume: 5
  year: 2014
  ident: B24
  article-title: Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction
  publication-title: Nat Commun
  doi: 10.1038/ncomms4485
– ident: B25
  doi: 10.1038/nature14115
– ident: B6
  doi: 10.1194/jlr.M500294-JLR200
– ident: B23
  doi: 10.1128/MCB.00596-14
– ident: B36
  doi: 10.1073/pnas.1521230113
– volume: 40
  start-page: 764
  issue: 8
  year: 2002
  ident: B40
  article-title: Tumor necrosis factor-alpha-induced accumulation of tumor suppressor protein p53 and cyclin-dependent protein kinase inhibitory protein p21 is inhibited by insulin in ME-180S cells
  publication-title: Clin Chem Lab Med
  doi: 10.1515/CCLM.2002.131
SSID ssj0014454
Score 2.6852994
Snippet Persistent, unresolved inflammation in adipose tissue is a major contributor to obesity-associated metabolic complications. However, the molecular links...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 834
SubjectTerms Adipocytes
Adipocytes - metabolism
Adipocytes - pathology
Adipose tissue
Animals
Apoptosis
Biomedical research
Body weight
Bone marrow
Complications and side effects
Cytokines
Diabetes
Ectopic expression
Exosomes
Exosomes - genetics
Exosomes - metabolism
Exosomes - pathology
Fat cells
Gene expression
Genetic aspects
Glucose
Glucose tolerance
Homeostasis
Inflammation
Inflammation - genetics
Inflammation - metabolism
Inflammation - pathology
Insulin
Insulin resistance
Intolerance
Intra-Abdominal Fat - metabolism
Intra-Abdominal Fat - pathology
KLF4 protein
Kruppel-Like Transcription Factors - genetics
Kruppel-Like Transcription Factors - metabolism
Macrophages
Macrophages - metabolism
Macrophages - pathology
Metabolism
Metabolites
Mice
Mice, Knockout
MicroRNA
MicroRNAs
MicroRNAs - genetics
MicroRNAs - metabolism
miRNA
Obesity
Obesity - genetics
Obesity - metabolism
Obesity - pathology
Overweight
Panniculitis - genetics
Panniculitis - metabolism
Panniculitis - pathology
Paracrine signalling
Phenotypes
Polarization
Risk factors
Title Adipocyte-secreted exosomal microRNA-34a inhibits M2 macrophage polarization to promote obesity-induced adipose inflammation
URI https://www.ncbi.nlm.nih.gov/pubmed/30667374
https://www.proquest.com/docview/2183563211
https://www.proquest.com/docview/2179409451
https://pubmed.ncbi.nlm.nih.gov/PMC6355214
Volume 129
WOSCitedRecordID wos000457479300038&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1558-8238
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014454
  issn: 0021-9738
  databaseCode: M7P
  dateStart: 20020701
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1558-8238
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014454
  issn: 0021-9738
  databaseCode: 7X7
  dateStart: 20020701
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1558-8238
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014454
  issn: 0021-9738
  databaseCode: 7RV
  dateStart: 20020701
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central (subscription)
  customDbUrl:
  eissn: 1558-8238
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014454
  issn: 0021-9738
  databaseCode: BENPR
  dateStart: 20020701
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLbYhhAv3C-FUQxCsJdoaRLb8RMq0yaGWKkKTH2LHNtdI9EkLCkCiR_POYkbFjQhJF784i-JEx-fS3z8HUJegNcgmDbKE6niEKBAkwZSe0oy64N8BEY3PLPvxWQSz-dy6n64VS6tcqMTG0VtCo3_yPfRlDMeQrzyuvzqYdUo3F11JTS2yA6yJIRN6t6020WIIuZYmEeeFGHsmIXAZu-_Ozgeofcte_boT618wSz1UyYv2KCjm_87-lvkhvM-6bgVl9vkis3vkGsnbn_9Lvk5NllZ6B-19Sr0J8EdpfZ7URUruGqFuXuzydgLI0WzfJmlWV3Rk4CuFNYBW4JmoiVGyu5oJ60LWjbZfpYWbf0BL8sNyJKhCp9TWbjNAkSyPT55j3w-Ovx08NZz9Rk8zUVYe6lh4K1wndpIxhD5BCpQsU11sAA_SvpSx4HkseKRUhD0ac5szI1vQmWRYic24X2ynRe5fUioGCnfgrEE59NGzNcSxMRwlSK9GhNGDcjeZpYS7cjLsYbGl6QJYkSQdBM6IM87aNkydlwGeopTnbSHTbtVnowZeFgCYjIOt2kQyJGRYxLOmVpXVXL84fQfQB9nPdArB1oUMGat3MEHeHPk3uohX_aQZy3z-GXA3R4QVILud2-kMHEqqUp-i-CAPOu68UpMs8ttsUYMqGcI-BlgHrQC333DsKkQK6IBEb2l0AGQqLzfk2fLhrAcndpgFD36-7Aek-vgjco2JX6XbNfna_uEXNXf6qw6H5ItMTvFdi6aNh6SnTeHk-ls2Kz5X8LwWvE
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9NAFB6VgoALeyFQ6IDYLlad8TKeA0JRoWpoElAoVW_ueGbSWCK2qR2gEr-J38h73qhRhbj0wCWX-Tzx8pZv7DffI-QpsAbuKS0tHkkfFijwEzGhLCk8Y4N9MK1KndkRn0yCgwPxYYX8bPbCYFllExPLQK1The_INzGVe74D65XX2RcLu0bh19WmhUZlFrvm5Bss2fJXwzfwfJ8xtv12b2vHqrsKWMrnTmFF2oMc66vIuCIAvs4kk4GJFJtB9he2UAETfiB9V0pYqijfM4Gvbe1Ig8IwgXZg3gvkIsTxPpaQ8el--9XCdb1a9blvCe4EtZIRcITNd1vDPrJ90cl_f2aBU2mwW6J5KudtX__f7tYNcq1m13RQucNNsmKSW-TyuK4fuE1-DHScpeqkMFaOfBnoNjXf0zxdwFELrE2cTgaW40oaJ_M4ioucjhldSOxzNofISzN8E1BvXaVFSrOymtHQtOqvYMWJBl_RVOL_5AammYHLVdtD75BP53Lta2Q1SRNzj1Del7YBMgDk2rierQS4gfZlhPJxHteyR142VhGqWpwde4R8DstFGmdha0A98qSFZpUiyVmgDTStsNpM20axcOABg-Sw5vRhmhKBGiAJFhkdyWWeh8P3-_8A-jjtgF7UoFkK56xkvbEDrhy1xTrI5x3kUaWsfhZwvQOEkKe6w43Vh3XIzcPfJt8jj9thPBLLCBOTLhED6ccWrgeYu5WDtffQKTvgcrdHeMf1WgAKsXdHknheCrIjaWd99_7fT2uDXNnZG4_C0XCy-4BcBeYtqvL_dbJaHC_NQ3JJfS3i_PhRGVUoOTxvx_wFtRyyaA
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLbGQNNeuDMKgxnE7SVq6lwcPyBUbVSUbaUaA-0tOLa7RqJJWVJgEr-MX8c5iRsWNCFe9sBLX_zFzeVcPifH3yHkCbAGHigtHZ7IEBYo8JMwoRwpAuOCfTCtKp3ZPT4aRUdHYrxCfi73wmBZ5TImVoFa5wrfkXcxlQehB-uV7sSWRYx3Bq_mXxzsIIVfWpftNGoT2TWn32D5Vrwc7sCzfsrY4PXh9hvHdhhwVMi90kl0APk2VInxRQTcnUkmI5MoNgEmIFyhIibCSIa-lLBsUWFgolC72pMGRWIi7cG8l8hljqLlVdnguPmC4fuBVYDuOYJ7kVU1Ar7Qfbs97CHzF61c-GdGOJMS2-WaZ_Lf4Nr_fOeuk6uWddN-7SY3yIrJbpK1fVtXcIv86Ot0nqvT0jgF8mig4dR8z4t8BkfNsGbxYNR3PF_SNJumSVoWdJ_RmcT-Z1OIyHSObwjsllZa5nReVTkamtd9F5w00-BDmkr8n8LANBNwxXrb6G3y4UKu_Q5ZzfLM3CWU96RrgCQA6TZ-4CoB7qFDmaCsXMC17JAXSwuJlRVtx94hn-Nq8cZZ3BhThzxuoPNaqeQ80BaaWVxvsm2iW9wPgFlyWIuGME2FQG2QDG3lWC6KIh6--_gPoPcHLdBzC5rkcM5K2g0fcOWoOdZCPmshj2vF9fOAmy0ghELVHl56QGxDcRH_Nv8OedQM45FYXpiZfIEYSEuu8APAbNTO1txDr-qMy_0O4S03bAAo0N4eydJpJdSOZJ71_Ht_P60tsgb-GO8NR7v3yToQclHvCtgkq-XJwjwgV9TXMi1OHlYBhpJPF-2XvwBHvLsK
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adipocyte-secreted+exosomal+microRNA-34a+inhibits+M2+macrophage+polarization+to+promote+obesity-induced+adipose+inflammation&rft.jtitle=The+Journal+of+clinical+investigation&rft.au=Pan%2C+Yong&rft.au=Hui%2C+Xiaoyan&rft.au=Hoo%2C+Ruby+Lai+Chong&rft.au=Ye%2C+Dewei&rft.date=2019-02-01&rft.pub=American+Society+for+Clinical+Investigation&rft.issn=0021-9738&rft.eissn=1558-8238&rft.volume=129&rft.issue=2&rft.spage=834&rft.epage=849&rft_id=info:doi/10.1172%2FJCI123069&rft_id=info%3Apmid%2F30667374&rft.externalDocID=PMC6355214
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9738&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9738&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9738&client=summon